Dr Kishtagari on the Impact of Momelotinib on the Management of Anemic Myelofibrosis

Ashwin Kishtagari, MD, discusses how momelotinib addresses unmet needs in the management of anemic myelofibrosis following disease progression on ruxolitinib.

Related Keywords

Ashwin Kishtagari , Ruxolitinib Jakafi , Vanderbilt University Medical Center ,